SCHEMBL11344401

SCHEMBL11344401

CCOC(=O)c1[nH]c2cc(F)c(F)cc2c1-c1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
HPGD P15428 4/20 0.49
CYP1A2 P05177 1/20 0.49
XBP1 P17861 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 4/20 0.47
KDM4E B2RXH2 8/20 0.46
HSD17B10 Q99714 3/20 0.46
CASP1 P29466 1/20 0.46
HTR6 P50406 1/20 0.45
LMNA P02545 2/20 0.44
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
POLB P06746 1/20 0.43
MDM2 Q00987 1/20 0.42
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11348164 0.91 ALDH1A1 (0.46) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11348650 0.86 ALDH1A1 (0.55) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11298738 0.83 ALDH1A1 (0.69) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11343435 0.83 ALOX15 (0.60) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11344420 0.83 ALDH1A1 (0.72) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11281404 0.83 ALDH1A1 (0.51) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11297186 0.80 ALDH1A1 (0.57) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11306213 0.79 HPGD (0.56) ALDH1A1HPGDCYP1A2XBP1CYP2C19
SCHEMBL11259837 0.79 CBFB (0.40) KMT2A
SCHEMBL11257258 0.78 CBFB (0.39) ALDH1A1HPGDKDM4EHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0010617-B1 NOVEL 2-SUBSTITUTED-3-HETEROCYCLYLINDOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1981-08-05 EP disclosed
EP-0010617-A1 Novel 2-substituted-3-heterocyclylindoles, their preparation and pharmaceutical compositions containing them SCHERING CORPORATION (US) 1980-05-14 EP disclosed